"Bloomberg: The Asia Trade" brings you everything you need to know to get ahead as the trading day begins in Asia. Bloomberg TV is live from Tokyo and Sydney with Shery Ahn and Paul Allen, getting insight and analysis from newsmakers and industry leaders on the biggest stories shaping global markets. (Source: Bloomberg)
"Bloomberg: The Asia Trade" brings you everything you need to know to get ahead as the trading day begins in Asia. Bloomberg TV is live from Tokyo and Sydney with Shery Ahn and Paul Allen, getting insight and analysis from newsmakers and industry leaders on the biggest stories shaping global markets. (Source: Bloomberg)
Pony AI has reported its first profitable quarter. Founder and CEO James Peng says the company plans to expand its robotaxi business both domestically and overseas, citing strong demand. Peng adds that the Middle East remains a key priority market for Pony AI. He spoke exclusively on "Bloomberg: The China Show." (Source: Bloomberg)
Pony AI has reported its first profitable quarter. Founder and CEO James Peng says the company plans to expand its robotaxi business both domestically and overseas, citing strong demand. Peng adds that the Middle East remains a key priority market for Pony AI. He spoke exclusively on "Bloomberg: The China Show." (Source: Bloomberg)
The average one-year price target for Worley (ASX:WOR) has been revised to $14.89 / share. This is a decrease of 12.71% from the prior estimate of $17.06 dated February 21, 2026. The price target is an average of many targets provided by analysts. The latest t
The average one-year price target for Worley (ASX:WOR) has been revised to $14.89 / share. This is a decrease of 12.71% from the prior estimate of $17.06 dated February 21, 2026. The price target is an average of many targets provided by analysts. The latest t
The average one-year price target for CytomX Therapeutics (NasdaqGS:CTMX) has been revised to $13.90 / share. This is an increase of 47.30% from the prior estimate of $9.44 dated February 21, 2026. The price target is an average of many targets provided by ana
The average one-year price target for CytomX Therapeutics (NasdaqGS:CTMX) has been revised to $13.90 / share. This is an increase of 47.30% from the prior estimate of $9.44 dated February 21, 2026. The price target is an average of many targets provided by ana
LordHenriVoton/E+ via Getty Images Fiscal year 2026 will mark yet another 12-month period of asset impairments , below-market performance, and ongoing problems for J. M. Smucker ( SJM ). The company owns a number of iconic brands in spreads, pet food, coffee, and baked goods, but the strong brand portfolio was not enough to offset certain capital allocation mistakes made in recent years. Consequen...
LordHenriVoton/E+ via Getty Images Fiscal year 2026 will mark yet another 12-month period of asset impairments , below-market performance, and ongoing problems for J. M. Smucker ( SJM ). The company owns a number of iconic brands in spreads, pet food, coffee, and baked goods, but the strong brand portfolio was not enough to offset certain capital allocation mistakes made in recent years. Consequently, the stock has fallen by 21% over the past 5-year period - significantly underperforming both the consumer staples sector and the equity market as a whole. Data by YCharts SJM's downfall in recent years has been a direct result of the company's acquisition frenzy , which I criticized back in 2020. The company, however, needed some of these deals in order to pivot away from its legacy brands and move into more attractive product categories. Unfortunately, for shareholders, this strategic move came at a significant cost that, as I noted a couple of years ago, was relatively easy to predict for those who are paying attention. Having said all that, a potential recovery is now within reach, but the way up won't be smooth sailing. Ongoing Problems SJM's most recent quarterly report outlined yet another round of impairment charges related to recent acquisitions, which confirms that the company did overpay for some of its largest deals as of late. We recognized a $508 million impairment charge related to the goodwill of the Sweet Baked Snacks reporting unit and a $454 million impairment charge related to the Hostess brand indefinite-lived trademark. These impairment charges are reflective of both near-term underperformance and a revised long-term expectations for both net sales and segment profit. Source: SJM Q3 2026 Earnings Transcript Right after the Hostess Brands deals, I warned investors of the risk involved and the high likelihood that the acquisition would result in shareholder value destruction. It's very important to recognize that these impairments are not a one-off t...
Copper rose on Friday — and was headed for its first weekly gain this month — on optimism that US efforts to end the war in Middle East would bear fruit and prevent a slowdown in global growth. President Donald Trump pushed back a deadline for Iran to strike a deal with the US or face more attacks. However, it’s still unclear who Washington is negotiating with, and the Wall Street Journal reported...
Copper rose on Friday — and was headed for its first weekly gain this month — on optimism that US efforts to end the war in Middle East would bear fruit and prevent a slowdown in global growth. President Donald Trump pushed back a deadline for Iran to strike a deal with the US or face more attacks. However, it’s still unclear who Washington is negotiating with, and the Wall Street Journal reported the Defense Department was considering sending as many as 10,000 additional troops to the Middle East, Most industrial metals have fallen this month on expectations the conflict will spur inflation and slow global growth. Aluminum has been the exception, given that the effective closure of the Strait of Hormuz has cut off about 9% of global supply, although it was also headed for a weekly increase. “Despite all the claims from the US side, there is hardly any easing of tensions in reality,” said Harry Jiang, a trader with China-Base Ningbo Group Co. “Many traders are taking a wait-and-see approach.” Investors are also monitoring a demand recovery in China, with copper inventories recording their biggest weekly drop this year. A slump in prices due to the war in Iran is boosting orders from fabricators Copper rose 0.8% to $12,244.50 a ton on the London Metal Exchange as of 11:37 a.m. in Shanghai, and was up 2.6% for the week. Aluminum was steady at $3,269 a ton, headed for a 1.7% weekly increase. Iron ore dropped 0.1% to $106.35 a ton in Singapore, and was poised for the first weekly decline in five.
The average one-year price target for Delta Electronics (TWSE:2308) has been revised to NT$1,696.71 / share. This is an increase of 17.67% from the prior estimate of NT$1,441.90 dated February 21, 2026. The price target is an average of many targets provided b
The average one-year price target for Delta Electronics (TWSE:2308) has been revised to NT$1,696.71 / share. This is an increase of 17.67% from the prior estimate of NT$1,441.90 dated February 21, 2026. The price target is an average of many targets provided b
The average one-year price target for ATN International (NasdaqGS:ATNI) has been revised to $70.38 / share. This is an increase of 76.92% from the prior estimate of $39.78 dated February 21, 2026. The price target is an average of many targets provided by anal
The average one-year price target for ATN International (NasdaqGS:ATNI) has been revised to $70.38 / share. This is an increase of 76.92% from the prior estimate of $39.78 dated February 21, 2026. The price target is an average of many targets provided by anal
The average one-year price target for Macy's (NYSE:M) has been revised to $19.59 / share. This is a decrease of 11.29% from the prior estimate of $22.08 dated February 21, 2026. The price target is an average of many targets provided by analysts. The latest ta
The average one-year price target for Macy's (NYSE:M) has been revised to $19.59 / share. This is a decrease of 11.29% from the prior estimate of $22.08 dated February 21, 2026. The price target is an average of many targets provided by analysts. The latest ta